MONOBACTAM ORGANIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS
as further described herein, and pharmaceutically acceptable salts and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds to treat infections such as those caused by Gram-negative bacteria..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Europäisches Patentamt - (2019) vom: 01. Aug. Zur Gesamtaufnahme - year:2019 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
AULAKH VIRENDER SINGH [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2019-08-01, Last update posted on www.tib.eu: 2024-04-17, Last updated: 2024-04-19 |
|---|
| Patentnummer: |
US2019231752 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003675297 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003675297 | ||
| 003 | DE-627 | ||
| 005 | 20240419122934.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240419s2019 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA003675297 | ||
| 035 | |a (EPA)US2019231752 | ||
| 035 | |a (EPA)52808201 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a AULAKH VIRENDER SINGH |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a MONOBACTAM ORGANIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2019-08-01, Last update posted on www.tib.eu: 2024-04-17, Last updated: 2024-04-19 | ||
| 520 | |a as further described herein, and pharmaceutically acceptable salts and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds to treat infections such as those caused by Gram-negative bacteria. | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a CASAREZ ANTHONY |e verfasserin |4 aut | |
| 700 | 0 | |a LIN XIAODONG |e verfasserin |4 aut | |
| 700 | 0 | |a LINDVALL MIKA |e verfasserin |4 aut | |
| 700 | 0 | |a MCENROE GLENN |e verfasserin |4 aut | |
| 700 | 0 | |a MOSER HEINZ ERNST |e verfasserin |4 aut | |
| 700 | 0 | |a RECK FOLKERT |e verfasserin |4 aut | |
| 700 | 0 | |a TJANDRA MEILIANA |e verfasserin |4 aut | |
| 700 | 0 | |a SIMMONS ROBERT LOWELL |e verfasserin |4 aut | |
| 700 | 0 | |a YIFRU AREGAHEGN |e verfasserin |4 aut | |
| 700 | 0 | |a ZHU QINGMING |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2019) vom: 01. Aug. |
| 773 | 1 | 8 | |g year:2019 |g day:01 |g month:08 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/52808201/publication/US2019231752A1?q=US2019231752 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2019 |b 01 |c 08 | ||